Clinical Use of Checkpoint Inhibition in Kidney Cancer

Based on a presentation by Hans J. Hammers, MD, PhD, at the ASCO Genitourinary Cancers Symposium A “plethora of agents” to inhibit programmed death 1 (PD-1) […]

Resistance Exercise Training in Patients With Genitourinary Cancers to Mitigate Treatment-Related Skeletal Muscle Loss

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Oliver K. Glass, PhD, Sundhar Ramalingam, MD, and Michael R. Harrison, MD Dr Glass […]

Challenges of Conducting Clinical Trials of Natural Products to Combat Cancer

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Channing J. Paller, MD, Samuel R. Denmeade, MD, and Michael A. Carducci, MD The […]

Checkpoint Inhibitors in Breast Cancer: Hype or Promise?

Heather L. McArthur, MD, MPH

H&O Could you provide a brief overview of immunotherapy? HM The concept of immunotherapy is not a new one. In fact, back in the 1890s, a […]

Personalized Treatment for Patients With Myelofibrosis

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Tapan M. Kadia, MD Associate Professor The University of Texas MD Anderson Cancer Center […]

Surveillance for Hepatocellular Carcinoma

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Catherine Frenette, MD Medical Director of Liver Transplantation Scripps Center for Organ Transplantation La […]

What Is Optimal First-Line Treatment of Unresectable or Advanced BRAF-Mutant Melanoma?

Michael B. Atkins, MD

H&O  How common are BRAF mutations in patients with melanoma? MA Approximately 50% of patients with melanoma have a V600E or V600K mutation in BRAF, each […]

Manipulating the Microbiome to Improve the Efficacy of Immunotherapy

Thomas Gajewski, MD, PhD

H&O What is known about the role of the gut microbiome in cancer? TG Research into the intersection between the commensal microbiota and cancer is just […]

Hem/Onc News

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Devon Schuyler Users of Dietary Supplements More Likely to Skip Chemotherapy for Breast Cancer […]

Letter From the Editor: When Breath Becomes Air

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Bruce D. Cheson, MD For my most recent book club meeting, I brought not […]

Back to Archive